Bahar Ahani

Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

Deidre Wilkins, Annefleur C Langedijk, Robert Jan Lebbink et al. · The Lancet Infectious Diseases · 2023 · 105 citations

Life Sciences, Infectious Diseases, Molecular Biology +14

Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials

Bahar Ahani, Kevin M. Tuffy, Anastasia A. Aksyuk et al. · Nature Communications · 2023 · 76 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11

Burden of Respiratory Syncytial Virus–Associated Acute Respiratory Infections During Pregnancy

Sébastien Kenmoe, Helen Y. Chu, Fatimah S. Dawood et al. · The Journal of Infectious Diseases · 2023 · 21 citations · Full text

Public Health, Infectious Diseases, Maternal Health +13

Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY)

Douglas Arbetter, Vancheswaran Gopalakrishnan, Anastasia A. Aksyuk et al. · Clinical Infectious Diseases · 2024 · 17 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study

Sarah F. Hak, Roderick P Venekamp, Marie‐Noëlle Billard et al. · The Journal of Infectious Diseases · 2023 · 16 citations · Full text

Public Health, Infectious Diseases, Pediatrics +11